|
Apr 8
|
GenSight Biologics Announces the Filing of its 2024 Universal Registration Document
|
|
Apr 7
|
GenSight Biologics Reports Cash Position as of March 31, 2025, and Provides Business Update
|
|
Jun 20
|
GenSight Biologics Renegotiates Financial Obligations and Provides Operational Updates
|
|
Jan 16
|
Laurence Rodriguez, Appointed CEO of GenSight Biologics in December 2023, Joins the Company’s Board of Directors
|
|
Dec 27
|
GenSight Biologics Provides Business and Financial Update
|
|
Dec 22
|
GenSight Biologics appoints Laurence Rodriguez as Chief Executive Officer
|